Vecchiet L, Giamberardino MA, de Bigontina P, Dragani L
Savastano S, Di C, Barrea L, Colao A
RETURN TO TOP February 2, 2016: EPIC trial results are scheduled to be announced at the ACVIM Forum in Denver on June 9 15 months from the end of the trial to publication of its results Why wait so long
Many users who try inulin supplements early in their GLP-1 protocols report it as one of the most uncomfortable supplement experiences they have had
Oral bioavailability for a bare tripeptide is expected to be very low due to GI enzymatic degradation, though the sublingual route bypasses first-pass hepatic metabolism
So people at greatest risk for deficiency include those with low stomach acid (e.g., older adults and people on proton pump inhibitors or antacids) or low IF production (known as pernicious anemia), people on medications that interfere with B12 absorption (such as metformin), people who have had gastric surgery, those with GI conditions that impair nutrient absorption (like celiac or Crohn's disease), and people on vegan and vegetarian diets
